[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
November 26, 2008

Debate Continues Over the Safety of Cold and Cough Medicines for Children

JAMA. 2008;300(20):2354-2356. doi:10.1001/jama.2008.647

In the wake of calls for the US Food and Drug Administration (FDA) to discourage the use of cold and cough medicines for children younger than 6 years, the makers of such products have agreed to change the products’ labels, the second labeling change in about a year.

In October, the Consumer Healthcare Products Association (CHPA), a group that represents the manufacturers of over-the-counter cold and cough products, announced that its members would voluntarily revise the labels of children's cold and cough medicines to indicate that the products should not be used in children younger than 4 years. The group also added a warning to the label of products containing antihistamines that they should not be used to sedate children.